A Journal of Postdoctoral Research.
     Login   |   Register   
    ISSN : 2328-9791
left right
Metformin: The ‘multitasker’
Lathika Mohanraj
Virginia Commonwealth University
Department of Family and Community Health Nursing, School of Nursing, Virginia Commonwealth University, Richmond, VA 23298
Metformin was the first drug synthesized to reduce the blood sugar levels, but was overshadowed by the advent of insulin and other drugs. Today, metformin is the primary drug prescribed for the effective treatment of non-insulin dependent diabetes mellitus, obesity and polycystic ovarian syndrome (1). Metformin inhibits hepatic gluconeogenesis through AMP-K dependent regulation of small heterodimer partner (SHP) and the expression of gluconeogenic genes (2). It also increases insulin sensitivity and fatty acid oxidation in skeletal muscle (3). Metformin performs it role as an anti-hypergycemic modulator by suppressing hepatic glucose output, and...................

home phone mail info@postdocjournal.com
twitter facebook social icon Social link You Tube sky
Click Here